ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
60,400
+500 (0.83%)
At close: May 19, 2026
Market Cap950.62B
Revenue (ttm)26.25B +100.2%
Net Income-2.85B
EPS-222.00
Shares Out15.74M
PE Ration/a
Forward PE110.62
Dividendn/a
Ex-Dividend Daten/a
Volume159,819
Average Volume274,744
Open58,500
Previous Close59,900
Day's Range56,800 - 62,800
52-Week Range13,740 - 153,800
Betan/a
RSI32.15
Earnings DateApr 10, 2026

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Founded 2012
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

In 2025, ROKIT Healthcare's revenue was 26.25 billion, an increase of 100.19% compared to the previous year's 13.11 billion. Losses were -2.85 billion, -62.79% less than in 2024.

Financial Statements